Moreover, while activating AKT1 mutations are rare in human breast cancers, they occur more frequently among luminal or HER2-enriched (2-4%) than basal-like tumors (0%) [4], suggesting a selection pressure towards increased Akt signaling in these neoplasms. This evidence concerns the gene AKT1 and breast carcinoma.